• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS LYSING SOLUTION 10X 150 TESTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS LYSING SOLUTION 10X 150 TESTS Back to Search Results
Catalog Number 347691
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/19/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd facs lysing solution 10x 150 tests contained ifu for different reagent.The following information was provided by the initial reporter: facslysing solution was received by application specialist for training purposes.The carton box with the reagent vial contained ifu for another reagent.No impact in this case as the reagent will be used by bd employee for the training and demo purposes.But if a customer receives a wrong ifu with the reagent, there might be reputation loss for bd, and the customer will have to do additional steps to get the right ifu for the reagent.
 
Manufacturer Narrative
After further evaluation of the complaint, it has been determined that the previously submitted mfr report# 2916837-2021-00437 was sent in error.This complaint is not mdr reportable.Per cfr regulation 809.3.This device is not considered an ivd used for clinical diagnosis and is therefore exempt from mdr reporting.
 
Event Description
It was reported that the bd facs lysing solution 10x 150 tests contained ifu for different reagent.The following information was provided by the initial reporter: facslysing solution was received by application specialist for training purposes.The carton box with the reagent vial contained ifu for another reagent.No impact in this case as the reagent will be used by bd employee for the training and demo purposes.But if a customer receives a wrong ifu with the reagent, there might be reputation loss for bd, and the customer will have to do additional steps to get the right ifu for the reagent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACS LYSING SOLUTION 10X 150 TESTS
Type of Device
NA
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
katie swenson
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key12815320
MDR Text Key284385212
Report Number2916837-2021-00437
Device Sequence Number1
Product Code GGK
Combination Product (y/n)N
Reporter Country CodeRS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/28/2023
Device Catalogue Number347691
Device Lot Number1026807
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2021
Initial Date FDA Received11/15/2021
Supplement Dates Manufacturer Received04/05/2022
Supplement Dates FDA Received04/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/26/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-